Venus Remedies has been awarded an oncology tender by the WHO-backed Pan American Health Organisation (PAHO), the world’s oldest international public health agency, for supplying essential cancer drugs to multiple Latin American countries. This achievement signifies a major milestone for the company, enhancing its contribution to global health initiatives and reinforcing its commitment to improving global health outcomes by providing life-saving medicines to those who need them the most.
The company has been entrusted with the responsibility of supplying a wide range of essential oncology drugs like bleomycin, carboplatin, cisplatin, cytarabine, doxorubicin, irinotecan, methotrexate, and vincristine. This prestigious tender award highlights Venus Remedies' commitment to advancing healthcare and its crucial role in the global battle against cancer.
Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers.
